NSIS-B.CO
NSIS-B.CO
DK0060336014
Novonesis (Novozymes A/S) B
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 4.157.600.000 3.833.500.000
8.5%
Cost of Revenue 1.916.100.000 2.024.000.000
5.3%
Gross Profit 2.241.500.000 1.809.500.000
23.9%
1.358.900.000 1.150.500.000
18.1%
Operating Income 882.600.000 659.000.000
33.9%
Pretax Income 743.400.000 417.100.000
78.2%
Net Income Common Stockholders 583.600.000 305.800.000
90.8%
-- --
--
-- --
--
ende